Aevi Genomic Medicine Announces Expansion of its Collaboration with The Children's Hospital of Philadelphia
February 21, 2017 17:27 ET
|
Aevi Genomic Medicine, Inc.
PHILADELPHIA, PA--(Marketwired - Feb 21, 2017) - Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that it has strengthened its discovery and research platform by extending...
Aevi Genomic Medicine Announces 2017 Investor Day
February 15, 2017 08:00 ET
|
Aevi Genomic Medicine, Inc.
PHILADELPHIA, PA--(Marketwired - Feb 15, 2017) - Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced that it will host an Investor Day with senior management and key opinion leaders...
Aevi Genomic Medicine to Present at the Leerink Partners 6th Annual Global Healthcare Conference
February 09, 2017 08:00 ET
|
Aevi Genomic Medicine, Inc.
PHILADELPHIA, PA--(Marketwired - Feb 9, 2017) - Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola, President and Chief Executive Officer, will...
Aevi Genomic Medicine Announces Enrollment of First Patient in Phase 1/2 Clinical Trial of AEVI-001 in 22q Deletion Syndrome
January 31, 2017 08:00 ET
|
Aevi Genomic Medicine, Inc.
PHILADELPHIA, PA--(Marketwired - Jan 31, 2017) - Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that the first patient has been dosed in a Phase 1/2 clinical trial to...
Aevi Genomic Medicine Announces Completion of Enrollment for Phase 2/3 SAGA Clinical Trial of AEVI-001 (NFC-1) in mGluR+ ADHD Adolescents
January 04, 2017 08:00 ET
|
Aevi Genomic Medicine, Inc.
PHILADELPHIA, PA--(Marketwired - Jan 4, 2017) - Aevi Genomic Medicine, Inc. (NASDAQ: GNMX)
Top-line results expected in Q1 2017
Aevi...
Medgenics to Present at the 28th Annual Piper Jaffray Healthcare Conference
November 22, 2016 08:00 ET
|
Medgenics, Inc.
PHILADELPHIA, PA--(Marketwired - Nov 22, 2016) - Medgenics, Inc. (NASDAQ: MDGN) today announced that Michael F. Cola, President and Chief Executive Officer, will present at the 28th Annual Piper...
Medgenics to Present at the Jefferies London Healthcare Conference
November 09, 2016 08:00 ET
|
Medgenics, Inc.
PHILADELPHIA, PA--(Marketwired - Nov 9, 2016) - Medgenics, Inc. (NASDAQ: MDGN) today announced that Michael F. Cola, President and Chief Executive Officer, will present at the Jefferies London...
Medgenics Reports Third Quarter 2016 Financial Results
November 03, 2016 08:00 ET
|
Medgenics, Inc.
PHILADELPHIA, PA--(Marketwired - Nov 3, 2016) - Medgenics, Inc. (NASDAQ: MDGN)
Presented Data Confirming Prevalence of Genetic Mutations in Pediatric ADHD at the 63rd...
Medgenics to Host Conference Call to Announce Third Quarter 2016 Financial Results
October 26, 2016 08:30 ET
|
Medgenics, Inc.
PHILADELPHIA, PA--(Marketwired - Oct 26, 2016) - Medgenics, Inc. (NASDAQ: MDGN) will host a conference call and live audio webcast on Thursday, November 3, 2016 at 8:30 a.m. EST to report financial...
Medgenics, Inc. to Begin Trading on NASDAQ Global Market
October 10, 2016 16:30 ET
|
Medgenics, Inc.
PHILADELPHIA, PA--(Marketwired - Oct 10, 2016) - Medgenics, Inc. (NYSE MKT: MDGN) (the "Company") announced today that it has been approved for listing on the NASDAQ Global Market, continuing to...